Radiation-induced prostate swelling during SBRT of the prostate

References

• Widmark A, Gunnlaugsson A, Beckman K, et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomized, non-inferiority, phase 3 trial. Lancet. 2019;394(10196):385–395.
   PubMed Web of Science ®Google Scholar
• Kishan AU, Dang A, Katz AJ, et al. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer. JAMA Netw Open. 2019;2(2):e188006.
   PubMed Web of Science ®Google Scholar
• Brand DH, Tree AC, Ostler P, PACE Trial Investigators, et al. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2019;20(11):1531–1543.
   PubMed Web of Science ®Google Scholar
• Jackson WC, Silva J, Hartman HE, et al. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and Meta-analysis of over 6,000 patients treated on prospective studies. Int J Radiat Oncol Biol Phys. 2019;104(4):778–789.
   PubMed Web of Science ®Google Scholar
• Foerster R, Zwahlen DR, Buchali A, et al. Stereotactic body radiotherapy for high-risk prostate cancer: a systematic review. Cancers. 2021;13(4):759.
   PubMed Web of Science ®Google Scholar
• Loblaw A. Stereotactic ablative body radiotherapy for intermediate- or high-risk prostate cancer. Cancer J. 2020;26(1):38–42.
   PubMed Web of Science ®Google Scholar
• Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 1999;43(1):57–66.
   PubMed Web of Science ®Google Scholar
• Debois M, Oyen R, Maes F, et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999;45(4):857–865.
   PubMed Web of Science ®Google Scholar
• Hamdan I, Bert J, Rest CCL, et al. Fully automatic deformable registration of pretreatment MRI/CT for image-guided prostate radiotherapy planning. Med Phys. 2017;44(12):6447–6455.
   PubMed Web of Science ®Google Scholar
• Wegener D, Zips D, Thorwarth D, et al. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data. Acta Oncol. 2019;58(1):88–94.
   PubMed Web of Science ®Google Scholar
• Gunnlaugsson A, Persson E, Gustafsson C, et al. Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow. Phys Imaging Radiat Oncol. 2019;9:89–91.
   PubMedGoogle Scholar
• Jonsson J, Nyholm T, Söderkvist K. The rationale for MR-only treatment planning for external radiotherapy. Clin Transl Radiat Oncol. 2019;18:60–65.
   PubMed Web of Science ®Google Scholar
• Lee YK, Bollet M, Charles-Edwards G, et al. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol. 2003;66(2):203–216.
   PubMed Web of Science ®Google Scholar
• Devic S. MRI simulation for radiotherapy treatment planning. Med Phys. 2012;39(11):6701–6711.
   PubMed Web of Science ®Google Scholar
• Kapanen M, Collan J, Beule A, et al. Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med. 2013;70(1):127–135.
   PubMed Web of Science ®Google Scholar
• Paulson ES, Erickson B, Schultz C, et al. Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning. Med Phys. 2015;42(1):28–39.
   PubMed Web of Science ®Google Scholar
• Tenhunen M, Korhonen J, Kapanen M, et al. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol. 2018;57(7):902–907.
   PubMed Web of Science ®Google Scholar
• Kerkmeijer LGW, Maspero M, Meijer GJ, et al. Magnetic resonance imaging only workflow for radiotherapy simulation and planning in prostate cancer. Clin Oncol (R Coll Radiol). 2018;30(11):692–701.
   PubMed Web of Science ®Google Scholar
• Tyagi N, Fontenla S, Zelefsky M, et al. Clinical workflow for MR-only simulation and planning in prostate. Radiat Oncol. 2017;12(1):119.
   PubMed Web of Science ®Google Scholar
• Christiansen RL, Jensen HR, Brink C. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer. Acta Oncol. 2017;56(6):787–791.
   PubMed Web of Science ®Google Scholar
• Köhler MVT, Grootel MV, Hoogeven R, et al. MR-only simulation for radiotherapy planning. Philips White Paper. 2015
   Google Scholar
• Tyagi N, Fontenla S, Zhang J, et al. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis. Phys Med Biol. 2017;62(8):2961–2975.
   PubMed Web of Science ®Google Scholar
• Persson E, Gustafsson C, Nordström F, et al. MR-OPERA: a multicenter/multivendor validation of magnetic resonance imaging-only prostate treatment planning using synthetic computed tomography images. Int J Radiat Oncol Biol Phys. 2017;99(3):692–700.
   PubMed Web of Science ®Google Scholar
• MR-only RT planning for the brain and pelvis with synthetic CT. Siemens White paper. 2019.
   Google Scholar
• Hentschel B, Oehler W, Strauss D, et al. Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol. 2011;187(3):183–190.
   PubMed Web of Science ®Google Scholar
• Seppälä T, Visapää H, Collan J, et al. Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities. Strahlenther Onkol. 2015;191(11):862–868.
   PubMed Web of Science ®Google Scholar
• King BL, Butler WM, Merrick GS, et al. Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2011;79(5):1350–1357.
   PubMed Web of Science ®Google Scholar
• Gunnlaugsson A, Kjellén E, Hagberg O, et al. Change in prostate volume during extreme hypo-fractionation analysed with MRI. Radiat Oncol. 2014;9:22.
   PubMed Web of Science ®Google Scholar
• Ma TM, Neylon J, Casado M, et al. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: a post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy. Radiother Oncol. 2022;167:203–210.
   PubMed Web of Science ®Google Scholar
• Willigenburg T, de Muinck Keizer DM, Peters M, et al. Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator. Clin Transl Radiat Oncol. 2021;27:50–56.
   PubMed Web of Science ®Google Scholar
• van der Wielen GJ, Mutanga TF, Incrocci L, et al. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers. Int J Radiat Oncol Biol Phys. 2008;72(5):1604–1611.
   PubMed Web of Science ®Google Scholar
• O'Neill AGM, Jain S, Hounsell AR, et al. Fiducial marker guided prostate radiotherapy: a review. Br J Radiol. 2016;89(1068):20160296.
   PubMed Web of Science ®Google Scholar
• Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001;50(1):265–278.
   PubMed Web of Science ®Google Scholar
• Mutanga TF, de Boer HC, van der Wielen GJ, et al. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys. 2011;81(4):1160–1167.
   PubMed Web of Science ®Google Scholar
• Litzenberg DW, Balter JM, Hadley SW, et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2006;65(2):548–553.
   PubMed Web of Science ®Google Scholar
• Vanhanen A, Poulsen P, Kapanen M. Dosimetric effect of intrafraction motion and different localization strategies in prostate SBRT. Phys Med. 2020;75:58–68.
   PubMed Web of Science ®Google Scholar
• Li JS, Lin MH, Buyyounouski MK, et al. Reduction of prostate intrafractional motion from shortening the treatment time. Phys Med Biol. 2013;58(14):4921–4932.
   PubMed Web of Science ®Google Scholar
• Kim J, Park JM, Choi CH, et al. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning. Radiat Oncol. 2019;14(1):139.
   PubMed Web of Science ®Google Scholar
• Tetar SU, Bruynzeel AME, Lagerwaard FJ, et al. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer. Phys Imaging Radiat Oncol. 2019;9:69–76.
   PubMedGoogle Scholar
• Mannerberg A, Persson E, Jonsson J, et al. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow. Radiat Oncol. 2020;15(1):168.
   PubMed Web of Science ®Google Scholar
• Lin Y, Liu T, Yang W, et al. The non-Gaussian nature of prostate motion based on real-time intrafraction tracking. Int J Radiat Oncol Biol Phys. 2013;87(2):363–369.
   PubMed Web of Science ®Google Scholar
• Ballhausen H, Li M, Hegemann N-S, et al. Intra-fraction motion of the prostate is a random walk. Phys Med Biol. 2015;60(2):549–563.
   PubMed Web of Science ®Google Scholar
• Poulsen PR, Schmidt ML, Keall P, et al. A method of dose reconstruction for moving targets compatible with dynamic treatments. Med Phys. 2012;39(10):6237–6246.
   PubMed Web of Science ®Google Scholar